NCT07412600

Brief Summary

The goal of this clinical trial is to learn whether low-load resistance training performed to muscle failure can produce similar increases in muscle size and strength as high-load resistance training in healthy untrained young adult males. The main questions it aims to answer are: Does low-load resistance training (30% of one-repetition maximum) performed to failure increase muscle strength and muscle size to a similar extent as high-load resistance training (75% of one-repetition maximum)? Are there differences in total training volume between low-load and high-load resistance training programs performed to failure? Researchers will compare a low-load resistance training group to a high-load resistance training group to determine whether the magnitude of changes in muscle strength and hypertrophy differs between the two approaches. Participants will: Be randomly assigned to either a low-load (30% 1RM) or high-load (75% 1RM) resistance training group Perform supervised leg extension exercises to the point of voluntary muscle fatigue three times per week for 6 weeks Complete muscle strength testing (one-repetition maximum) before and after the training period Undergo ultrasound measurements to assess muscle thickness and cross-sectional area of thigh muscles before and after the intervention

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 18, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2022

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2022

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

February 9, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 17, 2026

Completed
Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

6 months

First QC Date

February 9, 2026

Last Update Submit

February 14, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Maximal Dynamic Strength - Estimated One-Repetition Maximum (1RM) Using Submaximal Prediction and Epley Equation

    Maximal strength will be estimated using a submaximal 1RM prediction protocol (8-10 repetitions) following a standardized warm-up. The highest load completed within the target repetition range will be used to calculate 1RM using the Epley equation (1RM = Load × \[1 + 0.033 × repetitions\]). Results will be expressed in kilograms (kg), with higher values indicating greater strength. Assessed at baseline and Week 4.

    Baseline (Week 0) and immediately after completion of the 6-week intervention (Week 6)

  • Muscle Thickness (MT) and Cross-Sectional Area (CSA) - Assessed by B-Mode Ultrasonography (LOGIQ S8, GE Healthcare)

    Muscle thickness (cm) and cross-sectional area (cm²) of the rectus femoris and vastus intermedius will be assessed using B-mode ultrasonography (LOGIQ S8, GE Healthcare, 2-8 MHz linear probe). Three images per site will be averaged for analysis. Higher values indicate greater muscle hypertrophy. Measurements performed at baseline and post-intervention by a blinded assessor.

    Baseline (Week 0) and immediately after completion of the 6-week intervention (Week 6)

Secondary Outcomes (1)

  • Muscular Endurance - Repetitions to Volitional Failure at 50% of Estimated 1RM

    Baseline (Week 0) and immediately after completion of the 6-week intervention (Week 6)

Study Arms (2)

LLRT

EXPERIMENTAL
Other: Low-load resistance training (30% 1RM)

HLRT

EXPERIMENTAL
Other: High-load resistance training (75% 1RM)

Interventions

Participants perform unilateral or bilateral leg extension exercise at 30% of their individually determined one-repetition maximum (1RM). Each training session consists of sets performed to volitional muscular failure. Training is conducted three times per week for 6 weeks under direct supervision. Load is adjusted if necessary to maintain the target relative intensity. All repetitions are performed using a controlled movement tempo.

LLRT

Participants perform the same leg extension exercise at 75% of their individually determined one-repetition maximum (1RM). As in the LLRT group, sets are performed to volitional muscular failure. Training frequency (three sessions per week), duration (6 weeks), supervision, exercise selection, and movement tempo are identical to the LLRT group.

HLRT

Eligibility Criteria

Age18 Years - 28 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male sex
  • Age between 18 and 28 years
  • Healthy status as determined by self-report health screening
  • No participation in structured resistance training or lower-limb power training within the previous 12 months
  • Engaging only in recreational physical activity (no systematic lower-body resistance training)
  • Willingness to maintain usual daily routines throughout the study period
  • Agreement to refrain from any structured lower-body resistance training during the 6-week intervention
  • Provision of written informed consent

You may not qualify if:

  • Any current or recent musculoskeletal injury affecting lower-limb function
  • History or presence of cardiovascular disease
  • History or presence of metabolic disorders
  • Resting hypertension (≥140/90 mmHg)
  • Regular tobacco use
  • Use of medications known to affect neuromuscular performance
  • Inability or unwillingness to comply with the training protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Selcuk University

Meram, Konya, 04204, Turkey (Türkiye)

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

February 9, 2026

First Posted

February 17, 2026

Study Start

December 18, 2021

Primary Completion

June 20, 2022

Study Completion

July 2, 2022

Last Updated

February 18, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations